Vamorolone Shows Efficacy With Fewer Side Effects Over 48 Weeks

Vamorolone Shows Efficacy With Fewer Side Effects Over 48 Weeks

313288

Vamorolone Shows Efficacy With Fewer Side Effects Over 48 Weeks

Treatment with vamorolone continued to show a good safety profile and sustained efficacy across functional assessments after almost one year in boys with Duchenne muscular dystrophy (DMD), according to 48-week results of the Phase 2b VISION-DMD clinical trial. Data also showed no loss of efficacy in boys who switched from the corticosteroid prednisone to vamolorone. This switch was associated by investigators with a reversal of growth stunting and fewer side effects, including behavioral changes. “We…

You must be logged in to read/download the full post.